Search database
Filter
56
Text search: antipsychotic medications
Featured
Language
Document type
No document type
43
Manuals
3
Guidelines
3
Fact sheets
3
Training Material
2
Studies & Reports
2
Countries / Regions
Ethiopia
4
Global
2
India
1
Nepal
1
South Sudan
1
Syria
1
Brazil
1
Botswana
1
Western and Central Europe
1
Asia
1
Venezuela
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
IACAPAP
12
World Health Organization WHO
10
et al.
5
World Health Organization
3
A. Marconi
2
H. Gosney
2
Human Rights Watch
2
J. M. Rey
2
A. A. Olashore
1
A. Caye
1
A. Cohen, J. Eaton, B. Radtke, et al.
1
A. Stringaris
1
Academy of Medical Royal Colleges , England
1
Adrian Sondheimer
1
American Academy of Child and Adolescent Psychiatry
1
AOSIS Publishing
1
B. Frank‐Hatitchki: O. Ogunwobi
1
B. Vitiello
1
BioMed Central
1
C. Carandang
1
C. Freeman
1
C. Gray
1
C. S. Biskup, Martin Holtmann
1
Child and Adolescent Psychiatry and Mental Health
1
Corrado Barbui, Tarun Dua, Kavitha Kolappa et al.
1
D. Acosta
1
Drug Administration and Control Authority (DACA) of Ethiopia
1
E. Castro-Costa, et al.
1
E. Ista
1
F. D. Zepf
1
Ferrin, M.
1
Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA)
1
Food, Medicine and Healthcare Administration and Control Authority of Ethiopia
1
G. Jonsson
1
H. Knoester
1
H. Marval-Ospino
1
Hannah Metzger, Sina Wanderer & Veit Roessner
1
Inter-Agency Standing Comittee IASC
1
International Bank for Reconstruction and Development/ The World Bank
1
J. D. Machado
1
J. N. M. Schieveld
1
J. Perry, L. Palmer, P. Thom, et al.
1
Joseph M Rey
1
Joseph M. Rey, Francisco B. Assumpção Jr, Carlos A. Bernad, Füsun Çetin Çuhadaroğlu, Bonnie Evans, Daniel Fung, Gordon Harper, Loïc Loidreau, Yoshiro Ono, Dainius Pūras, Helmut Remschmidt, Brian Robertson, Olga A. Rusakoskaya, Kari Schleimer
1
K. Quy
1
Kishimoto T., Robenzadeh A, Leucht C, et al.
1
L. A. Rohde
1
Laura Asher, Charlotte Hanlon, Julian Eaton, et al.
1
M. Conceição do Rosário
1
M. Ferrin
1
M.J.
1
Mercado, S.
1
Ministry of Health & Family Welfare, India
1
Ministry of Health, Rwanda
1
N. Davies
1
National Institute of Mental Health NIH
1
Nimesh Desai, Dhanesh Gupta, Ram Avtar Singh, et al.
1
P. Gomes de Alvarenga
1
P. J. Frick
1
Pan American Health Organisation PAHO
1
PLOS Medicine
1
Prince
1
R. S. Mastrorosa
1
Regional Office for Europe
1
Royal College of Psychiatrists
1
S. MacPhee
1
Smith, Pamela
1
Southern African HIV Clinicians Society
1
Tarun Dua, Nicolas Clark, Neerja Chowdhary et al.
1
The South African Depression and Anxiety Group
1
UNHCR
1
United Nations Office on Drug and Crime UNODC
1
Vikram Patel, Dan Chisholm, Tarun Dua et al.
1
WHO
1
WHO South-East Asia New Delhi
1
World Health Organisation (WHO)
1
World Health Organization (Pacific Region)
1
World Health Organization (WHO) Regional Office for the Eastern Mediterranean
1
World Health Organization and Calouste Gulbenkian Foundation
1
World Health Organization, UN High Commissioner for Refugees
1
World Health Organization, UNICEF, United Nations Population Fund
1
Publication Years
Category
Countries
7
Clinical Guidelines
4
Public Health
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
42
COVID-19
2
Disability
1
Conflict
1
Natural Hazards
1
HIV
1
Global Health Education
1
Caregiver
1
Planetary Health
1
NCDs
1
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one ... more
Other disorders Chapter H.5.1
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Accessed April 16, 2019
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
Q8. SCOPING QUESTION: In people with bipolar disorders who require maintenance treatment, are a) antipsychotics or b) mood stabilizers (lithium, valproate or carbamazepine) effective and safe?
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Fourth Edition
6th edition
Introduction Chapter A.7
Mood disorders Chapter E.3 2016 edition
Psychiatry and Pediatrics Chapter I.5
Introduction Capter A.1 Ethics and international child and adolescent psychiatry
Introduction Chapter A.9
Anxiety disorders Chapter F.3
Externalising disorders Chapter D.2
Miscellaneous Child and adolescent psychiatric emergencies Chapter J.1